膳食营养摄入对非酒精性脂肪性肝病的影响

洪泽; 陈思颖; 杨文娟; 丁启龙

doi:10.3969/j.issn.1001-5256.2016.03.036

膳食营养摄入对非酒精性脂肪性肝病的影响

DOI: 10.3969/j.issn.1001-5256.2016.03.036

中国药科大学药学医学基础实验教学中心

详细信息

中图分类号: R575.5
计量
- 文章访问数: 1395
- HTML全文浏览量: 17
- PDF下载量: 413
- 被引次数: 0
出版历程
- 出版日期: 2016-03-20

Role of dietary intervention in nonalcoholic fatty liver disease

Experimental and Teaching Center of Medical Basis for Pharmacy, China Pharmaceutical University

摘要

摘要: 非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝脏疾病,但目前临床上仍没有针对NAFLD的有效治疗方法。生活方式尤其是饮食习惯的改变在NAFLD的治疗中起到重要的作用。综述了脂肪酸、糖类和蛋白质三大营养物质以及维生素在NAFLD发生和发展中的作用,指出NAFLD患者可以通过合理膳食改善疾病的发展。
- 脂肪肝 /
- 膳食疗法 /
- 综述
Abstract: Nonalcoholic fatty liver disease( NAFLD) is the most common chronic liver disease. However,at present,there are still no effective therapeutic methods for NAFLD in clinical practice. Lifestyle changes,especially changes in eating habits,play an important role in the treatment of NAFLD. This review summarizes the role of fatty acids,carbohydrates,proteins,and vitamins in the development and progression of NAFLD,and points out that a proper diet can help improve the condition of patients with NAFLD.
- fatty liver /
- diet therapy /
- review

HTML全文

参考文献(33)

[1] JORGE HM,ERAN E,CHENGCHENG J,et al.Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity[J].Nature,2012,482(7384):179-185.

[2]FAN JG.Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J].J Gastroenterol Hepatol,2013,28(Suppl 1):11-17.

[3]DIETRICH P,HELLERBRAND C.Non-alcoholic fatty liver disease,obesity and the metabolic syndrome[J].Best Pract Res Clin Gastroenterol,2014,28(4):637-653.

[4]RUSU E,JINGA M,ENACHE G,et al.Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C——a randomized trial[J].Nutr J,2013,12:119.

[5]QU M,SHEN W.Role of PI3K/Akt pathway in endoplasmic reticulum stress and apoptosis induced by saturated fatty acid in human steatotic hepatocytes[J].Chin J Hepatol,2015,23(3):194-199.(in Chinese)瞿梅,沈薇.PI3K/Akt对饱和脂肪酸诱导肝细胞脂变内质网应激及脂性凋亡的影响[J].中华肝脏病杂志,2015,23(3):194-199.

[6]GARCA-RUIZ I,SOLS-MUOZ P,FERNNDEZ-MOREIRA D,et al.In vitro treatment of Hep G2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis[J].Dis Model Mech,2015,8(2):183-191.

[7]GENTILE CL,PAGLIASSOTTI MJ.The role of fatty acids in the development and progression of nonalcoholic fatty liver disease[J].J Nutr Biochem,2008,19(9):567-576.

[8]ZIVKOVIC AM,GERMAN JB,SANYAL AJ.Comparative review of diets for the metabolic syndrome:implications for nonalcoholic fatty liver disease[J].Am J Clin Nutr,2007,86(2):285-300.

[9]BENATAR JR,STEWART RA.The effects of changing dairy intake on trans and saturated fatty acid levels-results from a randomized controlled study[J].Nutr J,2014,13(8):32-42.

[10]MACHADO RM,STEFANO JT,OLIVEIRA CP,et al.Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content[J].J Nutr,2010,140(6):1127-1132.

[11]DHIBI M,BRAHMI F,MNARI A,et al.The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease(NAFLD)in rats[J].Nutr Metab(Lond),2011,8(1):65-77.

[12]de ALMEIDA MM,LUQUETTI SC,SABARENSE CM,et al.Butter naturally enriched in cis-9,trans-11 CLA prevents hyperinsulinemia and increases both serum HDL cholesterol and triacylglycerol levels in rats[J].Lipids Health Dis,2014,13:200.

[13]PRIORE P,CAVALLO A,GNONI A,et al.Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease[J].IUBMB Life,2015,67(1):9-17.

[14]BARGUT TC,FRANTZ ED,MANDARIM-de-LACERDA CA,et al.Effects of a diet rich in n-3 polyunsaturated fatty acids on hepatic lipogenesis and beta-oxidation in mice[J].Lipids,2014,49(5):431-444.

[15]PICKOVA J.Importance of knowledge on lipid composition of foods to support development towards consumption of higher levels of n-3fatty acids via freshwater fish[J].Physiol Res,2009,58(Suppl1):s39-s45.

[16]ARENDT BM,COMELLI EM,MA DW,et al.Altered hepatic gene expression in non-alcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids[J].Hepatology,2015,61(5):1565-1578.

[17]VOS MB,Mc CLAIN CJ.Nutrition and nonalcoholic fatty liver disease in children[J].Curr Diab Rep,2008,8(5):399-406.

[18]MELLOUK Z,HACHIMI IDRISSI T,LOUCHAMI K,et al.The metabolic syndrome of fructose-fed rats:effects of long-chain polyunsaturatedω3 andω6 fatty acids.I.Intraperiteneal glucose tolerance test[J].Int J Mol Med,2011,28(6):1087-1092.

[19]BRAY GA.Soft drink consumption and obesity:it is all about fructose[J].Curr Opin Lipidol,2010,21(1):51-57.

[20]FAN JG,CAO HX.Role of diet and nutritional management in non-alcoholic fatty liver disease[J].J Gastroenterol Hepatol,2013,28(Suppl 4):81-87.

[21]ZHANG J,LI L,SONG P,et al.Randomized controlled trial of oatmeal consumption nersus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia[J].Nutr J,2012,11(1):54-62.

[22]BELLENTANI S,DALLE GRAVE R,SUPPINI A,et al.Behavior therapy for nonalcoholic fatty liver disease:the need for a multidisciplinary approach[J].Hepatology,2008,47(2):746-754.

[23]ALUKO EO,NNA VU,ADEKUNBI DA.The possible mechanisms through which dietary protein increases renal blood flow and glomerular filtration rate[J].Bri J Med Med Res,2015,7(6):458-469.

[24]BARCHETTA I,ANGELICO F,de BEN MD,et al.Strong association between non alcoholic fatty liver disease(NAFLD)and low 25(OH)vitamin D levels in an adult population with normal serum liver enzymes[J].BMC Med,2011,9:85.

[25]SEYDEL S,BEILFUSS A,KAHRAMAN A,et al.Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2[J].Turk J Gastroenterol,2011,22(4):400-407.

[26]KWOK RM,TORRES DM,HARRISON SA.Vitamin D and nonalcoholic fatty liver disease(NAFLD):is it more than just an association?[J].Hepatology,2013,58(3):1166-1174.

[27]ROLO AP,TEODORO JS,PALMEIRA CM.Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis[J].Free Radic Biol Med,2012,52(1):59-69.

[28]MUSSO G,ANTY R,PETTA S.Antioxidant therapy and drugs interfering with lipid metabolism:could they be effective in NAFLD patients?[J].Curr Pharm Des,2013,19(29):5297-5313.

[29]SHU X,ZHANG L,JI G.Vitamin E therapy in non-alcoholic fatty liver disease[J].Int J Clin Med,2014,5:87-92.

[30]BASU PP,SHAH NJ,ALOYSIUS MM,et al.Effect of vitamin E and alpha lipoic acid in nonalcoholic fatty liver disease:a randomized,placebo-controlled,open-label,prospective clinical trial(VAIN Trial)[J].Open J Gastroenterol,2014,4(5):199-207.

[31]CHALASANI N,YOUNOSSI Z,LAVINE JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J].Gastroenterology,2012,142(7):1592-609.

[32]LI Q,ZHUO QB,CHEN L,et al.Research advances in treatment of non-alcoholic fatty liver disease[J].J Clin Hepatol,2015,31(7):1135-1139.(in Chinese)李强,卓其斌,陈良,等.非酒精性脂肪性肝病的治疗进展[J].临床肝胆病杂志,2015,31(7):1135-1139.

[33]HUANG WS,WANG W.Basic management of nonalcoholic fatty liver disease[J].J Clin Hepatol,2010,26(2):156-159.(in Chinese)黄伟燊,王威.非酒精性脂肪肝病的基本管理[J].临床肝胆病杂志,2010,26(2):156-159.

施引文献

资源附件(0)

访问统计